Arzneiwerk VIDA Valuation Multiples

Arzneiwerk VIDA is valued at $2M as of November 2026, a 25.1x revenue multiple. In the last fiscal year, Arzneiwerk VIDA revenue was $75K and Arzneiwerk VIDA EBITDA was ($400K).

Arzneiwerk VIDA Overview

About Arzneiwerk VIDA

Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe.


Founded

1983

HQ

Germany

Employees

2

Financials (Last FY)

Revenue: $75K
EBITDA: ($400K)

EV

$2M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Arzneiwerk VIDA Financials

Arzneiwerk VIDA reported last fiscal year revenue of $75K and negative EBITDA of ($400K).

In the same fiscal year, Arzneiwerk VIDA generated $75K in gross profit, ($400K) in EBITDA losses, and had net loss of ($620K).


Arzneiwerk VIDA P&L

In the most recent fiscal year, Arzneiwerk VIDA reported revenue of $75K and EBITDA of ($400K).

Arzneiwerk VIDA is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (531%), and net margin of (823%).

See analyst estimates for Arzneiwerk VIDA
Last FY202320242025202620272028
Revenue$75K$2M$241K$75K
Gross Profit$75K$2M$240K$75K
Gross Margin100%87%100%100%
EBITDA($400K)($2M)($867K)($400K)
EBITDA Margin(531%)(111%)(361%)(531%)
EBIT Margin(546%)(102%)(246%)(546%)
Net Profit($620K)($2M)($971K)($620K)
Net Margin(823%)(113%)(403%)(823%)

Financial data powered by Morningstar, Inc.

Arzneiwerk VIDA Stock Performance

Arzneiwerk VIDA has current market cap of $2M, and enterprise value of $2M.

Market Cap Evolution


Arzneiwerk VIDA's stock price is $0.31.

Arzneiwerk VIDA share price increased by 83.7% in the last 30 days, and decreased by 46.8% in the last year.

Arzneiwerk VIDA has an EPS (earnings per share) of $-0.10.

See more trading valuation data for Arzneiwerk VIDA
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2M$2M-0.1%83.7%28.7%-46.8%$-0.10

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Arzneiwerk VIDA Valuation Multiples

Arzneiwerk VIDA trades at 25.1x EV/Revenue multiple, and (4.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for Arzneiwerk VIDA

Arzneiwerk VIDA Financial Valuation Multiples

As of November 19, 2026, Arzneiwerk VIDA has market cap of $2M and EV of $2M.

Arzneiwerk VIDA has a P/E ratio of (3.1x).

Last FY202320242025202620272028
EV/Revenue25.1x1.0x7.9x25.1x
EV/EBITDA(4.7x)(0.9x)(2.2x)(4.7x)
EV/EBIT(4.6x)(1.0x)(3.2x)(4.6x)
EV/Gross Profit25.1x1.1x7.9x25.1x
P/E(3.1x)(0.9x)(2.0x)(3.1x)
EV/FCF(2.6x)(1.5x)(1.5x)(2.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Arzneiwerk VIDA Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Arzneiwerk VIDA Margins & Growth Rates

In the most recent fiscal year, Arzneiwerk VIDA reported gross margin of 100%, EBITDA margin of (531%), and net margin of (823%).

See estimated margins and future growth rates for Arzneiwerk VIDA

Arzneiwerk VIDA Margins

Last FY20242025202720282029
Gross Margin100%100%100%
EBITDA Margin(531%)(361%)(531%)
EBIT Margin(546%)(246%)(546%)
Net Margin(823%)(403%)(823%)
FCF Margin(970%)(526%)(970%)

Arzneiwerk VIDA Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(88%)(69%)
Gross Profit Growth(86%)(69%)
EBITDA Growth(60%)(54%)
EBIT Growth(70%)(30%)
Net Profit Growth(56%)(36%)
FCF Growth0%(42%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Arzneiwerk VIDA Operational KPIs

Arzneiwerk VIDA's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Arzneiwerk VIDA
Last FY202320242025202620272028
Revenue per Employee$0.0M---
Opex per Employee$0.2M---
G&A Expenses to Revenue158%-157%158%
Opex to Revenue646%190%346%646%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Arzneiwerk VIDA Competitors

Arzneiwerk VIDA competitors include Cyfrowe Centrum Serwisowe, Boxlight, Exalt, DNA X, InCoax Networks, Verbicom, Maxcom, Cambium Networks, Indeco and Hammer Technology Holdings.

Most Arzneiwerk VIDA public comparables operate across Networking Hardware.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Cyfrowe Centrum Serwisowe$28M$169K0.1x-10.0x-
Boxlight$109M($4M)0.3x0.3x(8.6x)-
Exalt$5M$3K0.3x-449.4x-
DNA X-($2M)--(1.8x)-
InCoax Networks$5M($3M)0.0x-(0.0x)-
Verbicom$11M$24K0.5x-224.6x-
Maxcom$26M$273K0.3x-24.9x-
Cambium Networks$160M($23M)0.4x-(3.0x)-

This data is available for Pro users. Sign up to see all Arzneiwerk VIDA competitors and their valuation data.

Start Free Trial

Acquisitions by Arzneiwerk VIDA

Arzneiwerk VIDA has acquired 1 company to date.

Last acquisition by Arzneiwerk VIDA was on October 25th 2021. Arzneiwerk VIDA acquired GVL Rechenzentrum for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Arzneiwerk VIDA

GVL Rechenzentrum
Description
GVL Rechenzentrum GmbH is a Dortmund-based pharmacy data center developing software tools for electronic prescriptions and health services research in Germany. Collaborating with mid-sized data centers, the firm simplifies mandatory e-prescription handling for pharmacies and insurers while enabling cost-effective clinical studies. Founded in 2001, GVL processes millions of transactions annually through its secure cloud infrastructure.
HQ CountryGermany
HQ City
Berlin
Deal Date25 Oct 2021
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Arzneiwerk VIDA acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Arzneiwerk VIDA

When was Arzneiwerk VIDA founded?Arzneiwerk VIDA was founded in 1983.
Where is Arzneiwerk VIDA headquartered?Arzneiwerk VIDA is headquartered in Germany.
How many employees does Arzneiwerk VIDA have?As of today, Arzneiwerk VIDA has over 2 employees.
Is Arzneiwerk VIDA publicly listed?Yes, Arzneiwerk VIDA is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of Arzneiwerk VIDA?Arzneiwerk VIDA trades under TLIK ticker.
When did Arzneiwerk VIDA go public?Arzneiwerk VIDA went public in 1998.
Who are competitors of Arzneiwerk VIDA?Arzneiwerk VIDA main competitors include Cyfrowe Centrum Serwisowe, Boxlight, Exalt, DNA X, InCoax Networks, Verbicom, Maxcom, Cambium Networks, Indeco, Hammer Technology Holdings.
What is the current market cap of Arzneiwerk VIDA?Arzneiwerk VIDA's current market cap is $2M.
What is the current revenue of Arzneiwerk VIDA?Arzneiwerk VIDA's last fiscal year revenue is $75K.
What is the current EV/Revenue multiple of Arzneiwerk VIDA?Current revenue multiple of Arzneiwerk VIDA is 25.1x.
Is Arzneiwerk VIDA profitable?No, Arzneiwerk VIDA is not profitable.
How many companies Arzneiwerk VIDA has acquired to date?As of November 2026, Arzneiwerk VIDA has acquired 1 company.
What was the largest acquisition by Arzneiwerk VIDA?None of the M&A deals Arzneiwerk VIDA has completed have disclosed valuations.
What companies Arzneiwerk VIDA acquired?Arzneiwerk VIDA acquired GVL Rechenzentrum.
In how many companies Arzneiwerk VIDA has invested to date?Arzneiwerk VIDA hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Arzneiwerk VIDA

Lists including Arzneiwerk VIDA

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial